Janus Henderson Group
INO icon

Janus Henderson Group’s Inovio Pharmaceuticals INO Stock Holding History

Janus Henderson Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.77M Hold
3,308,406
– – ﹤0.01% 917
2025
Q4 		$5.77M Buy
3,308,406
+42,146
+1% +$92.8K ﹤0.01% 887
2025
Q3 		$7.63M Buy
+3,266,260
New +$6.25M ﹤0.01% 807
2023
Q2 		– Sell
-8,510
Closed -$83.7K – 2638
2023
Q1 		$83.7K Buy
8,510
+5,000
+142% +$85.2K ﹤0.01% 2631
2022
Q4 		$65.5K Sell
3,510
-3,510
-50% -$79.6K ﹤0.01% 2397
2022
Q3 		$144K Buy
7,020
+3,520
+101% +$90.1K ﹤0.01% 2456
2022
Q2 		$73K Hold
3,500
– – ﹤0.01% 2516
2022
Q1 		$151K Buy
+3,500
New +$158K ﹤0.01% 2497

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return